Systemic light chain amyloidosis newly diagnosed - daratumumab - initial authority application form (PB341)

Use this form to apply for initial PBS-subsidised treatment with daratumumab for newly diagnosed systemic light chain amyloidosis.

Page last updated: 18 June 2024.
QC 63899